European Journal Of Clinical Investigation

Journal Title：European Journal Of Clinical Investigation

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

EJCI 考虑从最复杂的基础分子科学到广泛分支学科的应用临床和转化研究以及循证医学的任何原创贡献。EJCI 发表与人类生物学和疾病的遗传、分子、细胞或生理基础有关的高质量研究报告，以及涉及疾病的流行、诊断、过程、治疗和预防的研究。我们主要对与人类直接相关的研究感兴趣，但也鼓励提交可靠的体外和动物研究。该期刊非常重视使用创新方法以及实验室、临床和流行病学方法和技术组合的跨学科工作和研究。几类稿件（详细描述见下文）将被考虑：社论、原创文章（还包括随机临床试验、系统评价和荟萃分析）、评论（叙述性评论）、意见文章（包括辩论、观点和评论）；以及致编辑的信。

European Journal Of Clinical Investigation创刊于1970年，由Wiley-Blackwell Publishing Ltd出版商出版，收稿方向涵盖医学 - 医学：内科全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 约1月 ，影响因子指数4.4，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。